Healthcare provider profile · identity verified

Christopher A Zablocki, MD

Family Practice · MANITOWOC, WI · NPI 1871156349

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	307	86
Amlodipine Besylate	Amlodipine Besylate	234	74
Lisinopril	Lisinopril	202	62
Rosuvastatin Calcium	Rosuvastatin Calcium	179	58
Losartan Potassium	Losartan Potassium	158	46
Tamsulosin Hcl	Tamsulosin Hcl	154	45
Levothyroxine Sodium	Levothyroxine Sodium	152	37
Pantoprazole Sodium	Pantoprazole Sodium	138	38
Furosemide	Furosemide	135	36
Metoprolol Succinate	Metoprolol Succinate	132	31
Hydrochlorothiazide	Hydrochlorothiazide	121	38
Eliquis	Apixaban	117	20
Omeprazole	Omeprazole	114	46
Meloxicam	Meloxicam	108	43
Metformin Hcl Er	Metformin Hcl	103	28
Telmisartan	Telmisartan	91	27
Albuterol Sulfate Hfa	Albuterol Sulfate	88	39
Metformin Hcl	Metformin Hcl	88	25
Gabapentin	Gabapentin	82	33
Pregabalin	Pregabalin	81	19
Duloxetine Hcl	Duloxetine Hcl	80	23
Mirtazapine	Mirtazapine	75	26
Simvastatin	Simvastatin	75	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	73	19
Warfarin Sodium	Warfarin Sodium	72	16
Pravastatin Sodium	Pravastatin Sodium	70	20
Prednisone	Prednisone	70	52
Indapamide	Indapamide	67	23
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	64	24
Tizanidine Hcl	Tizanidine Hcl	59	30
Fluticasone Propionate	Fluticasone Propionate	57	26
Metoprolol Tartrate	Metoprolol Tartrate	56	21
Jardiance	Empagliflozin	55	19
Spironolactone	Spironolactone	55	21
Fluoxetine Hcl	Fluoxetine Hcl	54	12
Sertraline Hcl	Sertraline Hcl	51	16
Allopurinol	Allopurinol	49	19
Donepezil Hcl	Donepezil Hcl	47	13
Clopidogrel	Clopidogrel Bisulfate	45	13
Oxybutynin Chloride Er	Oxybutynin Chloride	43	13
Triamcinolone Acetonide	Triamcinolone Acetonide	43	27
Quetiapine Fumarate	Quetiapine Fumarate	39	11
Trazodone Hcl	Trazodone Hcl	39	suppressed
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Alendronate Sodium	Alendronate Sodium	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	37	11
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	37	14
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	35	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	suppressed
Finasteride	Finasteride	33	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	12
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	31	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	31	14
Topiramate	Topiramate	31	suppressed
Atenolol	Atenolol	30	11
Citalopram Hbr	Citalopram Hydrobromide	30	11
Diclofenac Sodium	Diclofenac Sodium	30	15
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	14
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	29	suppressed
Celecoxib	Celecoxib	27	suppressed
Propranolol Hcl Er	Propranolol Hcl	27	suppressed
Alprazolam	Alprazolam	26	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	26	25
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Clonazepam	Clonazepam	25	suppressed
Carvedilol	Carvedilol	24	suppressed
Glimepiride	Glimepiride	24	13
Glipizide	Glipizide	24	suppressed
Potassium Chloride	Potassium Chloride	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	23	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	22	11
Divalproex Sodium	Divalproex Sodium	22	suppressed
Montelukast Sodium	Montelukast Sodium	22	suppressed
Baclofen	Baclofen	21	suppressed
Famotidine	Famotidine	21	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	21	suppressed
Symbicort	Budesonide/Formoterol Fumarate	21	suppressed
Clonidine Hcl	Clonidine Hcl	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Ipratropium Bromide	Ipratropium Bromide	20	13
Wixela Inhub	Fluticasone Propion/Salmeterol	20	suppressed
Glipizide Er	Glipizide	19	suppressed
Januvia	Sitagliptin Phosphate	19	suppressed
Mounjaro	Tirzepatide	19	suppressed
Ondansetron Odt	Ondansetron	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Azithromycin	Azithromycin	18	16
Doxycycline Monohydrate	Doxycycline Monohydrate	18	12
Propranolol Hcl	Propranolol Hcl	18	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	18	suppressed
Aptiom	Eslicarbazepine Acetate	17	suppressed
Myrbetriq	Mirabegron	17	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	17	suppressed
Clonidine	Clonidine	16	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Chlorthalidone	Chlorthalidone	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	14
Fenofibrate	Fenofibrate Nanocrystallized	15	suppressed
Humulin R	Insulin Regular, Human	15	suppressed
Ondansetron Hcl	Ondansetron Hcl	15	12
Solifenacin Succinate	Solifenacin Succinate	15	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Testosterone	Testosterone	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Lorazepam	Lorazepam	12	suppressed
Ozempic	Semaglutide	12	suppressed
Xifaxan	Rifaximin	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Bumetanide	Bumetanide	11	suppressed
Buprenorphine	Buprenorphine	11	suppressed
Eszopiclone	Eszopiclone	11	suppressed
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	11	suppressed
Humulin N	Insulin Nph Human Isophane	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Naltrexone Hcl	Naltrexone Hcl	11	suppressed
Olanzapine	Olanzapine	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Rivastigmine	Rivastigmine Tartrate	11	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error